MiNK Therapeutics, Inc. (INKT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 47.61M |
| Enterprise Value | 39.43M |
| P/E Ratio | -5.1 |
| PEG Ratio | -0.3 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -4.37 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 774.84 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0 |
| Return On Equity | 0.83 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -181,745 |
| EBITDA | -12.31M |
| Net Income | -12.49M |
| Diluted EPS | -2.93 |
| Total Cash | 8.81B |
| Total Cash/Share | 1,753.17 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 1,228.31 |
| Book Value Per Share | 1,909.36 |
| 52-Week Change | -18.12 |
| 52-Week High | 16.98 |
| 52-Week Low | 8.48 |
| Moving Average 50 Days | 11.31 |
| Moving Average 200 Days | 11.45 |
| Average Volume | 22,156 |
| Shares Outstanding | 4.98M |
| % Held by Institutions | 2.64 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | January 28, 2025 |